E. Prinssen

775 total citations
22 papers, 671 citations indexed

About

E. Prinssen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, E. Prinssen has authored 22 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in E. Prinssen's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). E. Prinssen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). E. Prinssen collaborates with scholars based in Switzerland, France and Netherlands. E. Prinssen's co-authors include Mark S. Kleven, Wouter Koek, Ping‐Hung Kuo, Claus Riemer, Lih‐Chu Chiou, Pi‐Chuan Fan, A.R. Cools, Bart Ellenbroek, Françis C. Colpaert and Will Spooren and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

E. Prinssen

22 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Prinssen Switzerland	15	426	302	107	89	65	22	671
D. K. Grandy United States	4	361 0.8×	311 1.0×	116 1.1×	80 0.9×	69 1.1×	4	678
Katsumasa Miyasato Japan	11	363 0.9×	256 0.8×	88 0.8×	110 1.2×	86 1.3×	22	588
Marc R. Azar United States	13	438 1.0×	401 1.3×	57 0.5×	193 2.2×	69 1.1×	24	771
Yoshio Morita Japan	17	248 0.6×	211 0.7×	136 1.3×	121 1.4×	133 2.0×	58	733
Kimberly A. Leite‐Morris United States	20	508 1.2×	278 0.9×	43 0.4×	90 1.0×	161 2.5×	27	888
Kazuhito Ikeda Japan	14	219 0.5×	242 0.8×	61 0.6×	77 0.9×	77 1.2×	31	627
Susann Matthes Germany	10	219 0.5×	194 0.6×	56 0.5×	67 0.8×	62 1.0×	14	644
Bader J. Cassin United States	6	449 1.1×	218 0.7×	104 1.0×	24 0.3×	79 1.2×	7	634
Daniel Klamer Sweden	20	435 1.0×	320 1.1×	71 0.7×	139 1.6×	121 1.9×	34	790
Michela Andreoli Italy	12	434 1.0×	317 1.0×	41 0.4×	88 1.0×	84 1.3×	19	672

Countries citing papers authored by E. Prinssen

Since Specialization

Citations

This map shows the geographic impact of E. Prinssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Prinssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Prinssen more than expected).

Fields of papers citing papers by E. Prinssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Prinssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Prinssen. The network helps show where E. Prinssen may publish in the future.

Co-authorship network of co-authors of E. Prinssen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Prinssen. A scholar is included among the top collaborators of E. Prinssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Prinssen. E. Prinssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Edye, Michelle E., E. Prinssen, S. Bandinelli, et al.. (2019). Poly(I:C) source, molecular weight and endotoxin contamination affect dam and prenatal outcomes, implications for models of maternal immune activation. Brain Behavior and Immunity. 82. 160–166. 44 indexed citations

Saccone, Phillip, Agnieszka Sulima, K.C. Rice, et al.. (2016). Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 357(1). 17–23. 11 indexed citations

Goeldner, Celia, J.R. Frey, Laurence Ozmen, et al.. (2011). PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders. Growth Hormone & IGF Research. 21(5). 292–303. 28 indexed citations

Baas, Johanna M.P., et al.. (2009). Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine. Psychopharmacology. 205(1). 73–84. 17 indexed citations

Klumpers, Floris, E. Prinssen, Frank Roesch, et al.. (2009). Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans. Journal of Psychopharmacology. 24(5). 657–666. 22 indexed citations

Malherbe, Pari, Raffaello Masciadri, Roger D. Norcross, et al.. (2008). Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABA_Breceptors. British Journal of Pharmacology. 154(4). 797–811. 85 indexed citations

Jhee, S. S., Mark Yen, Larry Ereshefsky, et al.. (2008). Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers. Antimicrobial Agents and Chemotherapy. 52(10). 3687–3693. 47 indexed citations

Depoortère, Ronan, Laurent Bardin, Agnès L. Auclair, et al.. (2007). F15063, a compound with D₂/D₃antagonist, 5‐HT_1Aagonist and D₄partial agonist properties: (II) Activity in models of positive symptoms of schizophrenia. British Journal of Pharmacology. 151(2). 253–265. 38 indexed citations

Prinssen, E., et al.. (2006). The effects of serotonin reuptake inhibitors on locomotor activity in gerbils. Pharmacology Biochemistry and Behavior. 85(1). 44–49. 8 indexed citations

10.

Chiou, Lih‐Chu, et al.. (2006). Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications. Current Drug Targets. 8(1). 117–135. 106 indexed citations

11.

Prinssen, E.. (2002). Depletion of 5-HT Disrupts Prepulse Inhibition in Rats Dependence on the Magnitude of Depletion, and Reversal by a 5-HT Precursor. Neuropsychopharmacology. 26(3). 340–347. 42 indexed citations

12.

Prinssen, E., Wouter Koek, Françis C. Colpaert, & Mark S. Kleven. (2000). Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Behavioural Pharmacology. 11(3 & 4). 299–305. 19 indexed citations

13.

Prinssen, E., Wouter Koek, Jacques Vignon, Jean‐Marc Kamenka, & Mark S. Kleven. (1999). Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine-induced locomotion?. Psychopharmacology. 143(1). 8–14. 3 indexed citations

14.

Prinssen, E., Mark S. Kleven, & Wouter Koek. (1999). Interactions between neuroleptics and 5-HT 1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects. Psychopharmacology. 144(1). 20–29. 58 indexed citations

15.

Prinssen, E., Mark S. Kleven, & Wouter Koek. (1996). Repeated administration of cocaethylene induces context-dependent sensitization to its locomotor effects. Psychopharmacology. 124(4). 300–305. 9 indexed citations

16.

Prinssen, E., Mark S. Kleven, & Wouter Koek. (1996). Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin. Psychopharmacology. 128(2). 191–197. 33 indexed citations

17.

Prinssen, E., Mark S. Kleven, Jacques Vignon, J.M. Kamenka, & Wouter Koek. (1996). Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.. Journal of Pharmacology and Experimental Therapeutics. 276(3). 904–911. 19 indexed citations

18.

Cools, A.R., E. Prinssen, & Bart Ellenbroek. (1995). The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine. Psychopharmacology. 119(4). 428–439. 26 indexed citations

19.

Cools, A.R., E. Prinssen, & Bart Ellenbroek. (1992). INTERACTION BETWEEN AMINERGIC SYSTEMS IN MESOLIMBIC STRUCTURES: THE IMPORTANCE OF 5-HT2, D2 AND D1 RECEPTORS IN THE OLFACTORY TUBERCLE FOR THE ATYPICAL PROFILE OF NEUROLEPTICS.. Clinical Neuropharmacology. 15. 618A–619A. 4 indexed citations

20.

Cools, A.R., et al.. (1992). ROLE OF OLFACTORY TUBERCLE AND NUCLEUS ACCUMBENS IN THE EFFECTS OF CLASSICAL AND ATYPICAL NEUROLEPTICS. Behavioural Pharmacology. 3(Supplement). 18–18. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact